Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/MYH9/USP7/c-Myc axis
Rentao Hou, Yonghao Li, Xiaojun Luo, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 6, pp. 2553-2567
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Advances in the study of disulfidptosis in digestive tract tumors
Yue Chen, Dachuan Zhang, Huijuan Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
FGFR families: biological functions and therapeutic interventions in tumors
Qing Liu, Jiyu Huang, Weiwei Yan, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 39
MYH9: A key protein involved in tumor progression and virus-related diseases
Qing Liu, Chao Cheng, Jiyu Huang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116118-116118
Open Access | Times Cited: 13
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery
Junyu Wu, Guping Tang, Chien‐shan Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance
Longyang Liu, Chunlin Chen, Ping Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 14
Open Access | Times Cited: 20
Regulatory network and targeted interventions for CCDC family in tumor pathogenesis
Zhen Liu, Weiwei Yan, Shaohua Liu, et al.
Cancer Letters (2023) Vol. 565, pp. 216225-216225
Closed Access | Times Cited: 20
MYC in liver cancer: mechanisms and targeted therapy opportunities
Furong Liu, Zhibin Liao, Zhanguo Zhang
Oncogene (2023) Vol. 42, Iss. 45, pp. 3303-3318
Closed Access | Times Cited: 17
Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies
Haochun Jin, Dianxin Cui, Yu Fan, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103885-103885
Open Access | Times Cited: 7
MiR‐2110 induced by chemically synthesized cinobufagin functions as a tumor‐metastatic suppressor via targeting FGFR1 to reduce PTEN ubiquitination degradation in nasopharyngeal carcinoma
Shiyi Fang, Lanzhu Peng, Mengmin Zhang, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 6, pp. 3548-3562
Open Access | Times Cited: 4
Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway
Liangbo Sun, Ming He, Feng Li, et al.
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 4
CCDC65, a Gene Knockout that leads to Early Death of Mice, acts as a potentially Novel Tumor Suppressor in Lung Adenocarcinoma
Ziyan Zhang, Ping Xu, Zhe Hu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 10, pp. 4171-4186
Open Access | Times Cited: 19
MYH9 promotes malignant progression of glioma cells through regulating β-catenin stability via epithelial-mesenchymal transition signaling pathway
Zigui Chen, Chao Liu, Wei Zheng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Glioma cell membrane camouflaged cinobufotalin delivery system for combinatorial orthotopic glioblastoma therapy
Zibin Song, Liqian Zhao, Weiyi Fang, et al.
Nano Research (2023) Vol. 16, Iss. 8, pp. 11164-11175
Closed Access | Times Cited: 9
Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance
Kangnan Zhang, Zhenhua Zhu, Jingyi Zhou, et al.
Translational Oncology (2024) Vol. 49, pp. 102091-102091
Open Access | Times Cited: 3
Non-Muscle Myosin II A: Friend or Foe in Cancer?
Wasim Feroz, Briley SoYoung Park, Meghna Siripurapu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9435-9435
Open Access | Times Cited: 3
Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma
Zigui Chen, Xin Yan, Changfeng Miao, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Unveiling the enigmatic role of MYH9 in tumor biology: a comprehensive review
Yunkuo Li, Yujie Pan, Xiangzhe Yang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review
Eman Al-Balushi, Amina Al Marzouqi, Shima Tavoosi, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 1, pp. 197-213
Open Access | Times Cited: 2
ENKUR recruits FBXW7 to ubiquitinate and degrade MYH9 and further suppress MYH9‐induced deubiquitination of β‐catenin to block gastric cancer metastasis
Jiahao Liu, Zhan Liu, Weiwei Yan, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 10
Exploring the nexus between MYH9 and tumors: novel insights and new therapeutic opportunities
Zixuan Gou, Difei Zhang, Hongliang Cao, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities
Sunny Kumar, Malini Basu, Mrinal K. Ghosh
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 8, pp. 119827-119827
Closed Access | Times Cited: 1
In silico and in vivo verification of the mechanism of formononetin in treating hepatocellular carcinoma
Guiping Ma, Xu Pang, Yun Ran, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Cinobufotalin inhibits proliferation, migration and invasion in hepatocellular carcinoma by triggering NOX4/NLRP3/GSDMD-dependent pyroptosis
Chen Liu, Jianmin Wu, Zhiwen Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth
Jichun Gu, Xi Xiao, Caifeng Zou, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top